Paul Peter Tak

Chief Executive Officer, Candel Therapeutics.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Sep 11, 2026Sold 59,379 shares at $10.46 of Candel Therapeutics²
Sep 10, 2026Sold 220,866 shares at $11.50 of Candel Therapeutics²
Sep 10, 2026Exercised options 125,000 shares at $1.55 of Candel Therapeutics²
Jun 25, 2025Granted 42,826 shares at $4.67 of Candel Therapeutics³
Mar 19, 2025Sold 400 shares at $9.00 of Candel Therapeutics⁴
Mar 18, 2025Sold 25,772 shares at $8.77 of Candel Therapeutics⁴
Jan 15, 2025Sold 21,704 shares at $7.23 of Candel Therapeutics⁵
Jan 8, 2025Sold 21,172 shares at $8.22 of Candel Therapeutics⁶
Nov 29, 2024Sold 48,847 shares at $4.56 of Candel Therapeutics⁷
Nov 21, 2024Exercised options 12,900 shares at $1.55 of Candel Therapeutics⁸
Jul 17, 2024Sold 22,528 shares at $6.47 of Candel Therapeutics⁹
Jul 11, 2024Sold 20,293 shares at $5.97 of Candel Therapeutics¹⁰
Nov 28, 2023Shares withheld for tax 43,443 shares at $0.90 of Candel Therapeutics¹¹
Nov 26, 2023Granted 180,108 shares of Candel Therapeutics¹²
Dec 9, 2022Bought 12,935 shares at $1.92 of Candel Therapeutics¹³
Dec 8, 2022Bought 3,050 shares at $1.70 of Candel Therapeutics¹³
Nov 28, 2022Granted 195,906 shares of Candel Therapeutics¹⁴

The numbers on this page point here. Each one links to the record it came from.